Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation

Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 2001-08, Vol.194 (4), p.551-556
Hauptverfasser: Lukacs, N W, Prosser, D M, Wiekowski, M, Lira, S A, Cook, D N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 556
container_issue 4
container_start_page 551
container_title The Journal of experimental medicine
container_volume 194
creator Lukacs, N W
Prosser, D M
Wiekowski, M
Lira, S A
Cook, D N
description Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.
doi_str_mv 10.1084/jem.194.4.551
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2193496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71118318</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</originalsourceid><addsrcrecordid>eNqFkU1rGzEQhkVpqF23x1zDnnpbR6MvS5dAME1aMAmE9CzW8siWs1rZ2t1A_31VYpL0VBgYGD28vOIh5BzoHKgWl3uMczBiLuZSwgcyBSlobSTXH8mUUsZqoHQxIZ_7fk8pCCHVJzIBkCAU0Cm5e8DjGDJG7IbKp1wNO6zcDmN6Ch1WGR0ehnJeLh9UFbqqaVvM2-Cqw9jG1DX5d7n6tomxGULqvpAz37Q9fj3tGfl18_1x-aNe3d_-XF6vaic0HeqNcgoVR-mNl2gkoJPIwTunvN4szJor7VEZZSRzlCohvGHCaeYk03yz5jNy9ZJ7GNcRN660z01rDznEUsmmJth_X7qws9v0bBkYLowqAd9OATkdR-wHG0PvsG2bDtPY2wUAaF7mfyBoxhk1poD1C-hy6vuM_rUNUPtXlS2qbFFlhS2qCn_x_gtv9MkN_wPOfpEG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18232099</pqid></control><display><type>article</type><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</creator><creatorcontrib>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</creatorcontrib><description>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.194.4.551</identifier><identifier>PMID: 11514610</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Animals ; Asthma - immunology ; Asthma - metabolism ; Asthma - physiopathology ; Brief Definitive Report ; CCR6 protein ; Cytokines - metabolism ; Hypersensitivity - immunology ; Hypersensitivity - metabolism ; Hypersensitivity - physiopathology ; Immunoglobulin E - biosynthesis ; macrophage inflammatory protein 3^a ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Pneumonia - immunology ; Pneumonia - metabolism ; Pneumonia - physiopathology ; Receptors, CCR6 ; Receptors, Chemokine - genetics ; Receptors, Chemokine - metabolism ; Receptors, Chemokine - physiology ; Th2 Cells - immunology ; Th2 Cells - metabolism</subject><ispartof>The Journal of experimental medicine, 2001-08, Vol.194 (4), p.551-556</ispartof><rights>2001 The Rockefeller University Press 2001 The Rockefeller University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</citedby><cites>FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11514610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lukacs, N W</creatorcontrib><creatorcontrib>Prosser, D M</creatorcontrib><creatorcontrib>Wiekowski, M</creatorcontrib><creatorcontrib>Lira, S A</creatorcontrib><creatorcontrib>Cook, D N</creatorcontrib><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</description><subject>Animals</subject><subject>Asthma - immunology</subject><subject>Asthma - metabolism</subject><subject>Asthma - physiopathology</subject><subject>Brief Definitive Report</subject><subject>CCR6 protein</subject><subject>Cytokines - metabolism</subject><subject>Hypersensitivity - immunology</subject><subject>Hypersensitivity - metabolism</subject><subject>Hypersensitivity - physiopathology</subject><subject>Immunoglobulin E - biosynthesis</subject><subject>macrophage inflammatory protein 3^a</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Pneumonia - immunology</subject><subject>Pneumonia - metabolism</subject><subject>Pneumonia - physiopathology</subject><subject>Receptors, CCR6</subject><subject>Receptors, Chemokine - genetics</subject><subject>Receptors, Chemokine - metabolism</subject><subject>Receptors, Chemokine - physiology</subject><subject>Th2 Cells - immunology</subject><subject>Th2 Cells - metabolism</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rGzEQhkVpqF23x1zDnnpbR6MvS5dAME1aMAmE9CzW8siWs1rZ2t1A_31VYpL0VBgYGD28vOIh5BzoHKgWl3uMczBiLuZSwgcyBSlobSTXH8mUUsZqoHQxIZ_7fk8pCCHVJzIBkCAU0Cm5e8DjGDJG7IbKp1wNO6zcDmN6Ch1WGR0ehnJeLh9UFbqqaVvM2-Cqw9jG1DX5d7n6tomxGULqvpAz37Q9fj3tGfl18_1x-aNe3d_-XF6vaic0HeqNcgoVR-mNl2gkoJPIwTunvN4szJor7VEZZSRzlCohvGHCaeYk03yz5jNy9ZJ7GNcRN660z01rDznEUsmmJth_X7qws9v0bBkYLowqAd9OATkdR-wHG0PvsG2bDtPY2wUAaF7mfyBoxhk1poD1C-hy6vuM_rUNUPtXlS2qbFFlhS2qCn_x_gtv9MkN_wPOfpEG</recordid><startdate>20010820</startdate><enddate>20010820</enddate><creator>Lukacs, N W</creator><creator>Prosser, D M</creator><creator>Wiekowski, M</creator><creator>Lira, S A</creator><creator>Cook, D N</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010820</creationdate><title>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</title><author>Lukacs, N W ; Prosser, D M ; Wiekowski, M ; Lira, S A ; Cook, D N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-d6c6e63e5f9f5e951ec5e31fcc6f8d79b368fe696952c00644f924c82c5283db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Asthma - immunology</topic><topic>Asthma - metabolism</topic><topic>Asthma - physiopathology</topic><topic>Brief Definitive Report</topic><topic>CCR6 protein</topic><topic>Cytokines - metabolism</topic><topic>Hypersensitivity - immunology</topic><topic>Hypersensitivity - metabolism</topic><topic>Hypersensitivity - physiopathology</topic><topic>Immunoglobulin E - biosynthesis</topic><topic>macrophage inflammatory protein 3^a</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Pneumonia - immunology</topic><topic>Pneumonia - metabolism</topic><topic>Pneumonia - physiopathology</topic><topic>Receptors, CCR6</topic><topic>Receptors, Chemokine - genetics</topic><topic>Receptors, Chemokine - metabolism</topic><topic>Receptors, Chemokine - physiology</topic><topic>Th2 Cells - immunology</topic><topic>Th2 Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lukacs, N W</creatorcontrib><creatorcontrib>Prosser, D M</creatorcontrib><creatorcontrib>Wiekowski, M</creatorcontrib><creatorcontrib>Lira, S A</creatorcontrib><creatorcontrib>Cook, D N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lukacs, N W</au><au>Prosser, D M</au><au>Wiekowski, M</au><au>Lira, S A</au><au>Cook, D N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2001-08-20</date><risdate>2001</risdate><volume>194</volume><issue>4</issue><spage>551</spage><epage>556</epage><pages>551-556</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3alpha is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3alpha, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3alpha and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>11514610</pmid><doi>10.1084/jem.194.4.551</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 2001-08, Vol.194 (4), p.551-556
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2193496
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Asthma - immunology
Asthma - metabolism
Asthma - physiopathology
Brief Definitive Report
CCR6 protein
Cytokines - metabolism
Hypersensitivity - immunology
Hypersensitivity - metabolism
Hypersensitivity - physiopathology
Immunoglobulin E - biosynthesis
macrophage inflammatory protein 3^a
Mice
Mice, Inbred C57BL
Mice, Knockout
Pneumonia - immunology
Pneumonia - metabolism
Pneumonia - physiopathology
Receptors, CCR6
Receptors, Chemokine - genetics
Receptors, Chemokine - metabolism
Receptors, Chemokine - physiology
Th2 Cells - immunology
Th2 Cells - metabolism
title Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T13%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Requirement%20for%20the%20chemokine%20receptor%20CCR6%20in%20allergic%20pulmonary%20inflammation&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Lukacs,%20N%20W&rft.date=2001-08-20&rft.volume=194&rft.issue=4&rft.spage=551&rft.epage=556&rft.pages=551-556&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.194.4.551&rft_dat=%3Cproquest_pubme%3E71118318%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18232099&rft_id=info:pmid/11514610&rfr_iscdi=true